Recombinant adeno-associated virus (rAAV) is one of the prominent gene delivery vehicles
that has opened promising opportunities for novel gene therapeutic approaches. However …

Recombinant adeno-associated viruses (rAAVs) stand at the forefront of gene therapy
applications, holding immense significance for their safe and efficient gene delivery …

Viral vectors are poised to acquire a prominent position in modern medicine and
biotechnology owing to their role as delivery agents for gene therapies, oncolytic agents …

Recombinant adeno‐associated viral vectors (rAAVs) are one of the most used vehicles for
gene therapy, with five rAAV therapeutics commercially approved by the FDA. To improve …

The recombinant adeno-associated virus (rAAV) vector is among the most promising viral
vectors in gene therapy. However, the limited manufacturing capacity in human embryonic …

Gene therapy is poised to transition from niche to mainstream medicine, with recombinant
adeno-associated virus (rAAV) as the vector of choice. However, robust, scalable …

Introduction: Engineered 3D models employing human induced pluripotent stem cell
(hiPSC) derivatives have the potential to recapitulate the cell diversity and structure found in …

Membrane proteins are important components of the proteome and play key roles in many
biological processes, such as signal transduction, material transport, cell recognition, etc …

Adeno-associated viruses (AAV) are currently predominant viral transfer tools for gene
therapy, and efforts are being made to design faster and more efficient methods and …

Researchers and engineers came together in Lisbon at the 27th Meeting of the European
Society for Animal Cell Technology (ESACT 2022), to discuss the latest advances in …